TY  - GEN
AU  - Miyoshi,Toru
AU  - Hirohata,Atsushi
AU  - Usui,Shinichi
AU  - Yamamoto,Keizo
AU  - Murakami,Takashi
AU  - Komatsubara,Issei
AU  - Kusachi,Shozo
AU  - Ohe,Tohru
AU  - Nakamura,Kazufumi
AU  - Ito,Hiroshi
TI  - Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial
SN  - 1615-2573
PY  - 2014///1231
KW  - Adiponectin
KW  - blood
KW  - Aged
KW  - Angina, Stable
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - therapeutic use
KW  - Anti-Inflammatory Agents
KW  - Biomarkers
KW  - C-Reactive Protein
KW  - metabolism
KW  - Coronary Artery Disease
KW  - Coronary Vessels
KW  - drug effects
KW  - Disease Progression
KW  - Down-Regulation
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Inflammation Mediators
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Percutaneous Coronary Intervention
KW  - Plaque, Atherosclerotic
KW  - Prospective Studies
KW  - Tetrazoles
KW  - Time Factors
KW  - Treatment Outcome
KW  - Ultrasonography, Interventional
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1007/s00380-013-0343-0
ER  -